By Anthony Silva, WBZ NewsRadio 1030

BOSTON (CBS) – A five year old local biotech will be getting a $200 million upfront payment as part of its sale to a large Japanese drug company.

Boston Biomedical of Norwood is being purchased by Dainippon Sumitomo Pharma, in a deal that could ultimately be worth more than $700 million.

Boston Biomedical founder and CEO Chiang Li says his company is involved in cutting edge cancer research.

WBZ NewsRadio 1030’s Anthony Silva reports


Leave a Reply

Please log in using one of these methods to post your comment:

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s